Neurobiological Technologies Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

CFO

Dividend

Dec 18, 20120.05 USD/sh

Profile

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

URL

IPO date

Feb 16, 1994

Employees

Domiciled in

Incorporated in

Valuation

No data to show